Cycloserine

DEA Class; Rx

Common Brand Names; Capastat

  • Antitubercular Agents

Bacteriostatic or bactericidal

Inhibits cell wall synthesis

Indicated for treatment of Tuberculosis

Hypersensitivity

Alcohol use

Renal dysfunction, severe

History of seizure disorder, mental depression, severe anxiety or psychosis

  • Confusion
  • Restlessness
  • Drowsiness
  • Vertigo
  • Cardiac arrhythmia
  • Folate deficiency
  • Hyperreflexia
  • Dysarthria
  • Dizziness
  • Headache
  • Coma
  • Liver enzymes increased
  • Somnolence
  • Paresis
  • Seizure
  • Heart failure

Caution in patients with history of alcoholism (may increase seizures), anemia, impaired hepatic/renal function

CNS toxicity (depression, seizures, psychosis) may occur

Prolonged use may result in fungal or bacterial superinfection (C. difficile-associated diarrhea)

Pregnancy Category: C

Lactation: enters breast milk; safe

Active Tuberculosis

Initial: 250 mg PO q12hr for 14 days THEN

500 mg -1 g/day divided q12hr for 18-24 months; not to exceed 1 g/day

Monitor blood levels

UTI

Initial: 250 mg PO q12hr for first 14 days

Maintenance: 500 mg -1 g/day in divided doses; not to exceed 1 g/day

Monitor blood levels

Gaucher’s Disease (Orphan)

Orphan indication sponsor

  • Lev, Meir M.D.; The City College, City University Of NY Medical Sc, Convent Avenue at 138 Street; New York, NY 10031

Cycloserine

capsule

  • 250mg

About the Author

You may also like these

0